5/21/2013

A therapy that uses stem cells has reportedly restored the sight of a man who suffered retinal cell degeneration. He is part of a trial testing the safety of stem cell-derived retinal pigment epithelial cells in reversing damage caused by dry age-related macular degeneration or Stargardt's macular dystrophy, two common causes of blindness. The vision in the man's affected eye is said to have improved from 20/400 to 20/40.

Full Story:
New Scientist

Related Summaries